Treatment of Feline Lymphocytic Lymphoma/Chronic Inflammatory Enteropathy Complex With Low Dose Abdominal Cavity Radiation Therapy
Veterinary and Comparative Oncology · 2025
DOI: 10.1111/vco.70007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2025. Verfasst von Tracy L Gieger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Cat Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Enteritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: North Carolina State University.
Abstract (Originalsprache)
The goal of this prospective, single‐arm pilot study was to assess tolerability and clinical benefit for cats with histologically confirmed lymphocytic lymphoma/chronic inflammatory enteropathy complex (FLL/CIE) treated with low‐dose abdominal cavity radiation therapy (RT; 8 Gy total dose administered in four 2 Gy fractions). No cats received steroids or chemotherapy prior to RT. Fourteen cats were enrolled and 13 completed the study. Eight cats had enteropathy‐associated T cell lymphoma type II (FLL), and 6 cats had CIE (lymphoplasmacytic enteritis, 3 with concurrent eosinophilic enteritis). Nine of 13 cats (69%) had transient worsening of GI signs in the 1–3 weeks after RT, presumed secondary to RT and/or stress of travel/anaesthesia. Eight were managed as outpatients and one cat died after being syringe fed by the owner. Nine of the 12 remaining cats (75%; N = 6 with FLL and N = 3 with CIE) had a clinical benefit to treatment (resolution or improvement of GI signs as defined by owner surveys and body weight) that was sustained for > 340 days. Three cats experienced presumed or confirmed disease progression at 341, 465 and 449 days after RT and were treated with steroids. Six cats remained asymptomatic ( N = 5) or stable ( N = 1) at a median of 635 days after RT (range, 447–1014 days). Low‐dose abdominal cavity RT could be considered for cats that cannot tolerate steroids and/or for owners that cannot pill cats routinely. Further optimisation of the protocol and use of RT as a rescue treatment for cats that fail traditional therapies are considerations for further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
- Pathobiology and Diagnostic Investigation, Michigan State University College of Veterinary Medicine, Veterinary Diagnostic Laboratory, Lansing, Michigan, USA.
ORCID-Profile: Tracy L Gieger, Michael W Nolan
Förderung
- North Carolina State University
Zitieren
APA
Gieger, T. L., Nolan, M. W., Gookin, J., & Watson, V. E. (2025). Treatment of Feline Lymphocytic Lymphoma/Chronic Inflammatory Enteropathy Complex With Low Dose Abdominal Cavity Radiation Therapy. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70007
Vancouver
Gieger TL, Nolan MW, Gookin J, Watson VE. Treatment of Feline Lymphocytic Lymphoma/Chronic Inflammatory Enteropathy Complex With Low Dose Abdominal Cavity Radiation Therapy. Veterinary and Comparative Oncology. 2025. doi:10.1111/vco.70007
BibTeX
@article{Gieger2025,
author = {Gieger, Tracy L and Nolan, Michael W and Gookin, Jody and Watson, Victoria Elizabeth},
title = {Treatment of Feline Lymphocytic Lymphoma/Chronic Inflammatory Enteropathy Complex With Low Dose Abdominal Cavity Radiation Therapy},
journal = {Veterinary and Comparative Oncology},
year = {2025},
doi = {10.1111/vco.70007}
}
EUVIMED